FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns vaccines, particularly vaccines for meningococcal infections and diseases. Invention claims immunogenic composition for transport via mucosa, including capsular saccharides of at least two of the following serological groups: A, C and W135 and Y N. Meningitidis, as well as trialkylated chitosan.
EFFECT: enhanced production of immune response to meningococci in mucosa, possible balance shift of Th1/Th2 type responses.
16 cl, 24 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED BACTERIAL MENINGITIS VACCINES TO BE INTRODUCED THROUGH MUCOUS MEMBRANE | 2003 |
|
RU2378008C2 |
| METHOD OF CLEANING BACTERIAL CAPSULAR POLYSACCHARIDE NEISSERIA MENINGITIDIS OR HAEMOPHILUS INFLUENZAE AND METHOD FOR PREPARING VACCINE | 2002 |
|
RU2381814C2 |
| IMMUNOGENIC COMPOSITION | 2013 |
|
RU2634405C2 |
| VACCINES OF SOLUBILISED AND COMBINED CAPSULAR POLYSACCHARIDES | 2002 |
|
RU2528066C2 |
| KIT FOR PREPARING IMMUNOGENIC COMPOSITION FOR SEROGROUP B Neisseria meningitidis | 2008 |
|
RU2498815C2 |
| MENINGOCOCCAL fHBP POLYPEPTIDES | 2009 |
|
RU2475496C2 |
| MOLECULE CONTAINING spr0096 AND spr2021 | 2012 |
|
RU2636350C2 |
| POLYPEPTIDE VACCINES FOR WIDE PROTECTION AGAINST ROWS OF MENINGOCOCCUS GENERATIONS WITH INCREASED VIRULENCE | 2003 |
|
RU2333007C2 |
| MENINGOCOCCAL CONJUGATE VACCINATION | 2005 |
|
RU2379052C2 |
| NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS | 2018 |
|
RU2780425C2 |
